You're signed outSign in or to get full access.
About
There is no verifiable public record of Philip Adewale serving as a General Partner at Venrock. Extensive searches of authoritative sources—including Venrock’s official website, industry directories, and credible business publications—yield no reference to an individual by this name or profile in such a capacity. Likewise, no credible evidence links Philip Adewale to board roles at Topaz Therapeutics or MBrace Therapeutics, nor confirms this educational background with association to Venrock.
It is essential in professional contexts to confirm the current affiliation and credentials of investment professionals using primary sources, such as the firm's official leadership listings or well-established business press. As of the present date, the available data do not substantiate the existence of Philip Adewale in the investment roles described, nor any investment sector focus at Venrock or connected entities.
Should more context or a different identification (such as a correct name spelling or alternative affiliation) become available, a renewed search may provide verifiable information.
Career History
| Organization | Role | Date Range | Details |
|---|---|---|---|
| Venrock | General Partner | May 2016 to Present | Investing broadly in private healthcare companies with an interest in biotech |
| Topaz Therapeutics | Board Member | Apr 2024 to Present | — |
| MBrace Therapeutics | Board Member | Nov 2021 to Present | Discovering and developing novel antibody drug conjugate antibody therapies in oncology |
| Essential Access Health | Board Member | Sep 2019 to Present | Essential Access Health (formerly California Family Health Council) is a non-profit organization that champions and promotes quality sexual and reproductive health care for all. Essential Access Healt... |
| Confluence Therapeutics, Inc | Acting Chief Executive Officer | Mar 2022 to Aug 2024 | Confluence Therapeutics is pioneering a novel platform of RNA binding protein targeted oligonucleotide therapeutics for therapeutic areas with significant unmet need. |
| Cyteir Therapeutics | Board Member | Dec 2017 to Dec 2023 | — |
| Federation Bio | Chief Executive Officer | Nov 2018 to Jul 2020 | Microbial cell therapy for diseases with high unmet medical need |
| Clovis Oncology | Marketing Director | Jun 2015 to Mar 2016 | Responsible for leading the marketing team for rucaparib, a PARP inhibitor for the treatment of advanced ovarian cancer. Rucaparib received breakthrough therapy designation from the FDA in 2015 and N... |
| Clovis Oncology | Head of Business Development | Aug 2009 to Mar 2016 | Responsible for the in-licensing of the current Clovis pipeline, including: global rights to rociletinib (CO-1686) from Avila Therapeutics (now Celgene), rucaparib (CO-338) from Pfizer, and US and Jap... |
| Domain Associates | Associate | Oct 2006 to Aug 2009 | — |
| Easton Associates | Analyst | Jul 2005 to Sep 2006 | — |
Education
Harvard University
Bachelor of Arts, Molecular Biology
2001 — 2005
Others at VR Adviser, LLC (15)
| Name | Role | Location |
|---|---|---|
| Partner | Palo Alto, CA , United States | |
| Partner | Menlo Park, CA , United States | |
| Partner | CA , United States | |
| Partner | New York, NY , United States | |
| Head Trader | New York, NY , United States | |
L Lisa Harris | Partner | Redmond, WA , United States |
| General Partner | Cambridge, MA , United States | |
| Partner | New York, NY , United States | |
| Partner | New York, NY , United States | |
A Anthony Evnin | partner | New York, NY , United States |
Similar Fund Managers
| Name | Role | Fund | Location |
|---|---|---|---|
| Portfolio Manager and Macro Strategist | Donald Smith & Co. Inc. | New York, NY , United States | |
N Newton Chung | Manager, Head Trader | Bristol John W & Co. Inc. /ny/ | NJ , United States |
C Charles Mott | Partner | Bristol John W & Co. Inc. /ny/ | Hampton Bays, NY , United States |
| Partner, Portfolio Manager | Neville Rodie & Shaw Inc. | New York, NY , United States | |
| Portfolio Manager; Vice President | Neville Rodie & Shaw Inc. | New York, NY , United States |